奥锐特：奥锐特药业股份有限公司2024年环境、社会和公司治理（ESG）报告（英文）.pdf

1、Aurisco Pharmaceutical Co.,Ltd.2024 Environmental,Social,and Governance(ESG)Report02Table of ContentsAppendixes 82About the ReportMessage from the ChairmanAbout AuriscoESG Governance04060814Prudent Governance to Build A Solid Foundation for DevelopmentResponsibility Coordination to Draw a New Chapte

2、r in the IndustryPeople Foremost to Pass on Warmth and PowerGreen Development to Practice Low-Carbon OperationsInnovation-Driven Development to Create Lean Products1844Corporate Governance StrengtheningInternal Control FortificationCompliance with Business EthicsInformation SafeguardingInvestor Rela

3、tions ManagementProtection of Employees Rights and InterestsEnhancement in Democratic GovernanceImplementation of Welfare and CareSupport for Employee GrowthOccupational Health and SafetyImprovement of Peoples WellbeingEnhancement of Environmental ManagementStandardization of Pollution and Waste Man

4、agementOptimization of Resource UtilizationClimate Change ResponsePractices in Green OperationsKey PerformanceIndicator IndexFeedback Table20222325293860Contribution to Industrial DevelopmentSustainable Supply Chain404030Adherence to Innovation-Driven DevelopmentPursuit for the Premium QualityProvis

5、ion of High-Quality Service323436626465687079464852555882869403About the ReportThis is the 2024 Environmental,Social and Governance(ESG)Report issued by Aurisco Pharmaceutical Co.,Ltd.(hereinafter referred to as“Aurisco”,“the Company”or“we”),and is the first ESG report of the Company,which aims to p

6、rovide our stakeholders with comprehensive information on our ESG practices and relevant performance in 2024.Reference Standards The standards,frameworks and principles referenced for the preparation of the Report are as follows:GRI Sustainability Reporting Standards(GRI Standards 2021)issued by the